Welcome to World Journal of Gastrointestinal Oncology


The World Journal of Gastrointestinal Oncology (WJGO) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of gastrointestinal oncology.  It was launched on October 15, 2009 and is published monthly (12 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.


We encourage gastrointestinal oncologists worldwide to submit manuscripts to the WJGO describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.


The usual times related to all publication processes of the WJGO are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJGO’s acceptance rate: 46%.  Submit here >>

Published Issues
1 2 3 4

Atsushi Imagawa, PhD, Director, Doctor; Wasaburo Koizumi, MD, PhD, Professor; Dimitrios Roukos, MD, PhD, Professor


PubMed, PubMed Central.

Impact Factor

There is currently no impact factor.


1948-5204 (online)

Previous  |   Next  |   Latest  |   Archive
Contents Volume 8  Issue 4  April 15, 2016
Topic Highlight
MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer  
Rui Yi, Yao Li, Fei-Liang Wang, Gang Miao, Ruo-Mei Qi, Yan-Yang Zhao
World J Gastrointest Oncol 8(4):330-340. Published online Apr 15, 2016. doi: 10.4251/wjgo.v8.i4.330
Helicobacter pylori associated Asian enigma: Does diet deserve distinction?  
Syed Faisal Zaidi
World J Gastrointest Oncol 8(4):341-350. Published online Apr 15, 2016. doi: 10.4251/wjgo.v8.i4.341
Status of colitis-associated cancer in ulcerative colitis  
Tetsushi Kinugasa, Yoshito Akagi
World J Gastrointest Oncol 8(4):351-357. Published online Apr 15, 2016. doi: 10.4251/wjgo.v8.i4.351
Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas  
Crystal S Seldon, Lauren E Colbert, William A Hall, Sarah B Fisher, David S Yu, Jerome C Landry
World J Gastrointest Oncol 8(4):358-365. Published online Apr 15, 2016. doi: 10.4251/wjgo.v8.i4.358
Molecular therapeutics in pancreas cancer  
Vignesh Narayanan, Colin D Weekes
World J Gastrointest Oncol 8(4):366-379. Published online Apr 15, 2016. doi: 10.4251/wjgo.v8.i4.366
Targeting inflammation in pancreatic cancer: Clinical translation  
Colin William Steele, Nina Angharad Kaur Gill, Nigel Balfour Jamieson, Christopher Ross Carter
World J Gastrointest Oncol 8(4):380-388. Published online Apr 15, 2016. doi: 10.4251/wjgo.v8.i4.380
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours  
Rossana Berardi, Francesca Morgese, Mariangela Torniai, Agnese Savini, Stefano Partelli, Silvia Rinaldi, Miriam Caramanti, Consuelo Ferrini, Massimo Falconi, Stefano Cascinu
World J Gastrointest Oncol 8(4):389-401. Published online Apr 15, 2016. doi: 10.4251/wjgo.v8.i4.389
Colorectal cancers and chlorinated water  
Ahmed Mahmoud El-Tawil
World J Gastrointest Oncol 8(4):402-409. Published online Apr 15, 2016. doi: 10.4251/wjgo.v8.i4.402
Retrospective Study
Clinicopathological features of patients with middle third gastric carcinoma  
Jin Hong Kim, Jae Kyoon Joo, Seong Yeob Ryu, Ho Gun Kim, Jae Hyuk Lee, Dong Yi Kim
World J Gastrointest Oncol 8(4):410-415. Published online Apr 15, 2016. doi: 10.4251/wjgo.v8.i4.410